Naomi Dian Dixon
Family · Hot Springs, ARNPI 1760707251
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 39.9% of the total. Reporting peaked in 2024 at $912 and has fallen 61.1% since, to $355 in 2025.
Across 171 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$362
- Novartis$182
- Lilly USA, LLC$166
- Johnson & Johnson$166
- Dexcom, Inc.$143
- plus $738 from 23 others
What the payments were for
- Travel & lodging$401%
- Food & beverage$2,88499%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,167 |
| AstraZeneca | 21 | $362 |
| Novartis | 14 | $182 |
| Lilly USA, LLC | 12 | $166 |
| Johnson & Johnson | 9 | $166 |
| Dexcom, Inc. | 8 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 6 | $92 |
| Amgen(2 entities) | 4 | $69 |
| Novo Nordisk | 4 | $56 |
| Abbott | 3 | $54 |
| Boehringer Ingelheim | 3 | $49 |
| Merck | 2 | $32 |
| Lundbeck LLC | 2 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,925 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.
Other family in Hot Springs
- Kayla StanageHot Springs$10K
- Robert McDanielsHot Springs$9K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.